Protagonist Therapeutics (PTGX) EPS (Basic) (2015 - 2026)
Protagonist Therapeutics' (PTGX) quarterly EPS (Basic) came in at $0.06 in Q1 2026, up 131.58% year-on-year from $0.03 in Q1 2025, and up 108.57% quarter-over-quarter from -$0.7 in Q4 2025.
Protagonist Therapeutics (PTGX) EPS (Basic) (2015 - 2026) Analysis & Trends
Protagonist Therapeutics has disclosed EPS (Basic) across 12 years of filings, most recently posting $0.06 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at $0.06, up 131.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.81 (down 301.11% YoY), and the FY2025 annual result was -$2.05, down 145.86% from the prior year.
- EPS (Basic) came in at $0.06 for Q1 2026 at Protagonist Therapeutics, up from -$0.7 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $3.41 in Q1 2024 to a low of -$0.84 in Q2 2022.
- The 5-year median for EPS (Basic) is -$0.55 (2025), against an average of -$0.09.
- Across the five-year window, EPS (Basic) soared 608.96% in 2024 and slumped 132.86% in 2025, its largest moves.
- Protagonist Therapeutics' EPS (Basic) stood at -$0.7 in 2022, then soared by 174.29% to $0.52 in 2023, then surged by 309.62% to $2.13 in 2024, then plunged by 132.86% to -$0.7 in 2025, then soared by 108.57% to $0.06 in 2026.
- The last three EPS (Basic) figures came in at $0.06 (Q1 2026), -$0.7 (Q4 2025), and -$0.62 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - | 0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | -0.70 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.19 |
| Dec 31, 2024 | 2.13 |
| Sep 30, 2024 | -0.54 |
| Jun 30, 2024 | -0.50 |
| Mar 31, 2024 | 3.41 |
| Dec 31, 2023 | 0.52 |
| Sep 30, 2023 | -0.58 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -0.64 |
| Jun 30, 2022 | -0.84 |
| Mar 31, 2022 | -0.43 |
| Dec 31, 2021 | -0.77 |
| Sep 30, 2021 | -0.70 |
| Jun 30, 2021 | -0.69 |